Kaiser risk of new malignancies following breast cancer

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700564P
Awardee
Awarding agency
Obligated
$149,990

Award facts

Opportunity
Contract value 100% obligated
$149,990.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
B529 Special Studies/Analysis- Scientific Data
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Cancer Institute awarded a purchase order to Kaiser Foundation Hospitals for $149,990.00 on August 31, 2017, with ultimate completion on August 31, 2018, for research on risk of new malignancies following breast cancer. Work is performed at Kaiser Foundation Research Institute in Rockville, Maryland. The order carries firm fixed price terms under a full-and-open competition with no set-aside designation.

Quick answers

Who was awarded contract HHSN261201700564P?

HHSN261201700564P was awarded to Kaiser Foundation Hospitals by National Cancer Institute (National Institutes of Health) on August 31, 2017.

How much is contract HHSN261201700564P worth?

The government has obligated $149,990 on HHSN261201700564P.

Was contract HHSN261201700564P competed?

The extent of competition for HHSN261201700564P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login